Recently, levels of matriptase, a transmembrane serine protease, were shown elevated in ovarian cancer, acting via the activation of PAR2 inducing the signaling of PI3K/Akt and MMP9 promoted the dislodging of cell–cell contacts [29]. The gene discussed is F2RL1; the disease is ovarian carcinoma.